Chinese expert consensus on the diagnosis and treatment of IgG 4 related diseases

VernacularTitle:IgG 4相关性疾病诊治中国专家共识
Author: Wen ZHANG ; Lingli DONG ; Jian ZHU ; Yanying LIU ; Yan ZHAO ; Xiaofeng ZENG ; Shuyang ZHANG
From: Chinese Journal of Internal Medicine 2021;60(3):192-206
CountryChina
Language:Chinese
Abstract: IgG 4 related disease (IgG 4-RD) is an immune medicated rare disease, characterized with chronic inflammation and fibrosis in the involved organs, it is a systemic disease affected nearly every anatomic site of the body, usually involvement of multiple organs, and with diverse clinical manifestations. Due to the the relative novelty of the disease and under-recognition, the overall level of diagnosis and treatment in China is uneven. Till now, there is no relevant expert consensus or guidance of IgG 4-RD in China. In order to further improve the understanding and standardize the management of IgG 4-RD, on the basis of summarizing domestic and international experience, the China Alliance For Rare Diseases, together with the Chinese Rheumatology Association, organized an expert group and established the Chinese expert consensus on the diagnosis and treatment of IgG 4 related diseases.